What pandemic? DexCom Q2 top line up 34%, earnings up 541%

DexCom (NASDAQ:DXCM) Q2 results:

Revenues: $451.8M (+34.3%), Sensor & other sales: $364.5M (+40.0%).

Net income: $46.3M (+541.0%); non-GAAP net income: $77.1M (+888.5%); EPS: $0.48 (+500.0%); non-GAAP EPS: $0.79 (+887.5%).

Non-GAAP EBITDA: $122.6M (+167.1%); non-GAAP EBITDA margin: 27.1%.

2020 guidance: Revenue: ~$1.85B; non-GAAP EBITDA margin: at least 24%.

https://seekingalpha.com/news/3596256-what-pandemic-dexcom-q2-top-line-up-34-earnings-up-541